CANCER : Oral monitoring of a pediatric patient during chemotherapy treatment

Patients with leukemia or lymphoma undergoing chemotherapy frequently develop alterations of the oral cavity. 

A direct effect of the drug on the oral mucosa or the associated myelosuppressive action are the two main mechanisms associated with side effects such as mucositis, dry mouth, bleeding, bone alterations, teeth disorders, pain and infections. 

An ongoing oral assessment must be performed to promote the early identification of oral complications. 


A previous instrument used developed by Nebraska University, the Oral Assessment Guide (OAG) showed as a comprehensive, accurate tool for assessing oral integrity in children with cancer during and after chemotherapy. 

The OAG is a guide of oral evaluation initially proposed by Eilers, Peterson and Berger in 19884 and modified for Cheng et al. to assess changes in the oral mucosa resulting from antineoplastic treatment using chemotherapy. 

This instrument allows to evaluate 8 items, according to the scales of impaired oral health, with assigned values 1-3 for each item, as follows: 1 for conditions where it is checked normality; 2, for the verification of mild to moderate changes in relation to the epithelial integrity or function and 3 for a severe impairment. 

At the end, the total checked for mucositis varies from 8 to 24, without a cutoff between these values for the estimation of mucositis. 

The purpose of this article is to describe an oral monitoring in an 11 year-old male with Hodgkin lymphoma during chemotherapy treatment using a modified Oral Assessment Guide. 

Revista Cubana de Estomatología 
Isabella Lima Arrais Ribeiro, Ana Maria Gondim Valença, Paulo Rogério Ferreti Bonan, Fabíola Galbiatti de Carvalho Carlo



Facebook comments: